Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume 133, Issue 3, Pages 296-306
Publisher
Wiley
Online
2011-04-05
DOI
10.1111/j.1365-2567.2011.03439.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Circulating CD4+CD25highFoxp3+ Regulatory T Cells Kill Autologous CD8+ but Not CD4+ Responder Cells by Fas-Mediated Apoptosis
- (2014) L. Strauss et al. JOURNAL OF IMMUNOLOGY
- A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1-Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
- (2010) B. E. Wahlin et al. CLINICAL CANCER RESEARCH
- Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph Nodes
- (2010) Alexandre Boissonnas et al. IMMUNITY
- T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies
- (2010) Camilla A. Lindqvist et al. IMMUNOLOGY
- Role of CD4+Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer
- (2010) Debora Martorelli et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Altered B Cell Development and Anergy in the Absence of Foxp3
- (2010) S. M. Leonardo et al. JOURNAL OF IMMUNOLOGY
- Antigens in chronic lymphocytic leukemia—Implications for cell origin and leukemogenesis
- (2010) Anders Rosén et al. SEMINARS IN CANCER BIOLOGY
- The Role of Cytotoxic and Regulatory T cells in Relapsed/Refractory Hodgkin Lymphoma
- (2010) Aashiyana F. Koreishi et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4+perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype
- (2009) James A. Walton et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Many Roles of FAS Receptor Signaling in the Immune System
- (2009) Andreas Strasser et al. IMMUNITY
- Structural aspects of the FOXP3 regulatory complex as an immunopharmacological target
- (2009) Zhaocai Zhou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cutting Edge: Regulatory T Cells Directly Suppress B Cells in Systemic Lupus Erythematosus
- (2009) N. Iikuni et al. JOURNAL OF IMMUNOLOGY
- Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
- (2008) K. Ekstrom Smedby et al. BLOOD
- Relationship between CD107a expression and cytotoxic activity
- (2008) Esin Aktas et al. CELLULAR IMMUNOLOGY
- Appraisal of immune response in lymphoproliferative syndromes: A systematic review
- (2008) Tomás Álvaro et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4+CD25– cells
- (2008) Tineke Aarts-Riemens et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
- (2008) A. Tzankov et al. HAEMATOLOGICA
- FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity
- (2008) Zhaocai Zhou et al. IMMUNOLOGIC RESEARCH
- STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25− effector T cells
- (2008) Laura Passerini et al. INTERNATIONAL IMMUNOLOGY
- Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis
- (2008) Na-Ri Lee et al. LEUKEMIA & LYMPHOMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started